We are live on
!
Find out more
SC
Sessa Capital Portfolio holdings
AUM
$5.98B
1-Year Est. Return
99.85%
This Fund
S&P 500
This Quarter
Est. Return
-7.36%
1 Year Est. Return
+99.85%
3 Year Est. Return
+146.79%
5 Year Est. Return
+201.69%
10 Year Est. Return
+788.83%
AUM
$1.4B
AUM Growth
-$431M
(-24%)
Cap. Flow
+$43.7M
Cap. Flow
% of AUM
3.12%
Top 10 Holdings %
Top 10 Hldgs %
81.3%
Holding
37
New
4
Increased
2
Reduced
4
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Haleon
HLN
|
+$110M |
| 2 |
PRVB
Provention Bio, Inc. Common Stock
PRVB
|
+$40.5M |
| 3 |
Corebridge Financial
CRBG
|
+$35M |
| 4 |
EHAB
Enhabit
EHAB
|
+$16.2M |
| 5 |
Bausch + Lomb
BLCO
|
+$5.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chemours
CC
|
+$72.8M |
| 2 |
Corteva
CTVA
|
+$34.8M |
| 3 |
Embecta
EMBC
|
+$31.4M |
| 4 |
ONL
Orion Office REIT
ONL
|
+$15.1M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
+$3.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 30.13% |
| 2 | Healthcare | 24.19% |
| 3 | Financials | 15.43% |
| 4 | Miscellaneous | 9.08% |
| 5 | Materials | 5.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSVT
26
DELISTED
2seventy bio
TSVT
| $4.45M | 0.32% |
305,633
-35,669
| -10% | -$529K |
|
|
LKFT
27
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
| $3.5M | 0.25% |
82,000
| – | – |
|
28
RxSight
RXST
$234M
| $1.63M | 0.12% |
135,779
-28,503
| -17% | -$391K |
|
29
MacroGenics
MGNX
$257M
| $847K | 0.06% |
244,864
| – | – |
|
|
BHR
30
Braemar Hotels & Resorts
BHR
$128M
| $112K | 0.01% |
25,951
| – | – |
|
|
31
Acadia Pharmaceuticals
ACAD
$4.61B
| – | – |
-249,000
| Closed | -$3.51M |
|
32
PUT
Coinbase
COIN
$45.4B
| – | – |
-200,000
| Closed | -$9.4M |
|
|
33
Corteva
CTVA
$55.6B
| – | – |
-642,092
| Closed | -$34.8M |
|
|
ONL
34
Orion Office REIT
ONL
$141M
| – | – |
-1,373,963
| Closed | -$15.1M |
|
35
PUT
Tesla
TSLA
$1.41T
| – | – |
-1,500,000
| Closed | -$337M |
|
|
AMPS
36
DELISTED
Altus Power
AMPS
| – | – |
-331,090
| Closed | -$2.09M |
|
Similar funds
DWM
DAS
AUB
FMWA
JPH
DRZID
HW
CIC
Sessa Capital's Q3 2022 Portfolio in Review
As of Q3 2022, Sessa Capital held 37 positions worth $1.4B, down 24% from $1.83B the previous quarter. Its ten largest holdings account for 81% of the portfolio.
Sessa Capital deployed $43.7M of net new capital in Q3 2022, opening 4 new positions and adding to 2 existing holdings. Its largest new stake was Haleon: 17,062,710 shares worth $104M.
By sector, the portfolio is most concentrated in Communication Services at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Chemours, an estimated $72.8M trimmed.
- Sessa Capital's largest Q3 2022 buy was Haleon: 17,062,710 shares worth $104M.
- Sessa Capital added most to Provention Bio, Inc. Common Stock in Q3 2022, an estimated $40.5M increase.
- Sessa Capital's biggest Q3 2022 reduction was Chemours, cutting an estimated $72.8M.
- Sessa Capital fully exited Corteva in Q3 2022, selling an estimated $34.8M.
- Sessa Capital's ten largest holdings make up 81% of its $1.4B portfolio in Q3 2022.
- Sessa Capital opened 4 new positions and closed 6 in Q3 2022.
- Sessa Capital's portfolio value fell 24% quarter-over-quarter to $1.4B.
Based on Sessa Capital's 13F filing for Q3 2022, filed 14 Nov 2022.